Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Fri, 04 Sep 2026 16:05:00 -0400

WAYNE, Pa., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced the grant of inducement equity awards to six new employees. The Compensation Committee of the Board of Directors of Avalo approved the grants of nonstatutory stock options to purchase an aggregate of 78,000 shares of common stock (the “Options”) as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

The Options were granted on

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Fri, 04 Sep 2026 16:05:00 -0400

The Options were granted on

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Thu, 03 Sep 2026 07:00:00 -0400

WAYNE, Pa., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced that management will participate in the following investor conferences:

Cantor Global Healthcare Conference 2026

Fireside Chat
September 10, 2026, at 8:00 am ET

Morgan Stanley 24th Annual Global Healthcare Conference

1x1 meetings only
September 16, 2026

H.C. Wainwright 28th Annual Global Investment Conference

Presentation
September 16, 2026, at 8:30 am ET

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Thu, 03 Sep 2026 07:00:00 -0400

Cantor Global Healthcare Conference 2026

Fireside Chat
September 10, 2026, at 8:00 am ET

Morgan Stanley 24th Annual Global Healthcare Conference

1x1 meetings only
September 16, 2026

H.C. Wainwright 28th Annual Global Investment Conference

Presentation
September 16, 2026, at 8:30 am ET

Form 4 Avalo Therapeutics, Inc. For: Aug 17 Filed by: Sullivan Christopher Ryan

Tue, 25 Aug 2026 19:03:00 -0400

si-local-file:///var/storage/secattach/20260825/26975956.html

Form 4 Avalo Therapeutics, Inc. For: Aug 17 Filed by: Doyle Mittie

Tue, 25 Aug 2026 19:03:00 -0400

si-local-file:///var/storage/secattach/20260825/26975991.html

Form 4 Avalo Therapeutics, Inc. For: Aug 17 Filed by: Sullivan Christopher Ryan

Wed, 19 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260819/26950140.html

Form 4 Avalo Therapeutics, Inc. For: Aug 17 Filed by: Doyle Mittie

Wed, 19 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260819/26950142.html

Form 144 Avalo Therapeutics, Inc. Filed by: Sullivan Christopher Ryan

Tue, 18 Aug 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260818/26944529.html

Form 144 Avalo Therapeutics, Inc. Filed by: Doyle Mittie

Mon, 17 Aug 2026 16:49:00 -0400

si-local-file:///var/storage/secattach/20260817/26938630.html

Form 144 Avalo Therapeutics, Inc. Filed by: Sullivan Christopher Ryan

Mon, 17 Aug 2026 16:48:00 -0400

si-local-file:///var/storage/secattach/20260817/26938602.html

Form 144 Avalo Therapeutics, Inc. Filed by: Sullivan Christopher Ryan

Mon, 17 Aug 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260817/26938191.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Nantahala Capital Management, LLC

Fri, 14 Aug 2026 16:49:00 -0400

si-local-file:///var/storage/secattach/20260814/26932190.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Fri, 14 Aug 2026 16:48:00 -0400

si-local-file:///var/storage/secattach/20260814/26932089.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Caligan Partners LP

Fri, 14 Aug 2026 16:48:00 -0400

si-local-file:///var/storage/secattach/20260814/26932122.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P

Fri, 14 Aug 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260814/26929957.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: T. Rowe Price Investment Management, Inc.

Fri, 14 Aug 2026 10:40:00 -0400

si-local-file:///var/storage/secattach/20260814/26926666.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Avoro Capital Advisors LLC

Fri, 14 Aug 2026 09:01:00 -0400

si-local-file:///var/storage/secattach/20260814/26925531.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Deep Track Capital, LP

Fri, 14 Aug 2026 08:25:00 -0400

si-local-file:///var/storage/secattach/20260814/26925044.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Affinity Asset Advisors, LLC

Thu, 13 Aug 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260813/26920952.html

Form 4 Avalo Therapeutics, Inc. For: Aug 10 Filed by: Doyle Mittie

Wed, 12 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260812/26912923.html

Form 4 Avalo Therapeutics, Inc. For: Aug 11 Filed by: Riley Jennifer

Wed, 12 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260812/26912929.html

Form 144 Avalo Therapeutics, Inc. Filed by: Riley Jennifer

Tue, 11 Aug 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20260811/26906158.html

Form 144 Avalo Therapeutics, Inc. Filed by: Doyle Mittie

Mon, 10 Aug 2026 16:48:00 -0400

si-local-file:///var/storage/secattach/20260810/26898816.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: FMR LLC

Fri, 07 Aug 2026 11:05:00 -0400

si-local-file:///var/storage/secattach/20260807/26889278.html

StreetInsider.com News Articles

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Form 4 Avalo Therapeutics, Inc. For: Aug 17 Filed by: Sullivan Christopher Ryan

Form 4 Avalo Therapeutics, Inc. For: Aug 17 Filed by: Doyle Mittie

Form 4 Avalo Therapeutics, Inc. For: Aug 17 Filed by: Sullivan Christopher Ryan

Form 4 Avalo Therapeutics, Inc. For: Aug 17 Filed by: Doyle Mittie

Form 144 Avalo Therapeutics, Inc. Filed by: Sullivan Christopher Ryan

Form 144 Avalo Therapeutics, Inc. Filed by: Doyle Mittie

Form 144 Avalo Therapeutics, Inc. Filed by: Sullivan Christopher Ryan

Form 144 Avalo Therapeutics, Inc. Filed by: Sullivan Christopher Ryan

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Nantahala Capital Management, LLC

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Caligan Partners LP

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: T. Rowe Price Investment Management, Inc.

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Avoro Capital Advisors LLC

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Deep Track Capital, LP

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Affinity Asset Advisors, LLC

Form 4 Avalo Therapeutics, Inc. For: Aug 10 Filed by: Doyle Mittie

Form 4 Avalo Therapeutics, Inc. For: Aug 11 Filed by: Riley Jennifer

Form 144 Avalo Therapeutics, Inc. Filed by: Riley Jennifer

Form 144 Avalo Therapeutics, Inc. Filed by: Doyle Mittie

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: FMR LLC